Center for Biomedical Research

Knoxville, Tennessee 37919

0 studies enrolling now · 9 studies all time

What they study most

Advanced Breast Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Chronic Myeloproliferative Disorders, Coronary Artery Disease, Head and Neck Cancer, Leukemia, Lymphoma, Lymphoproliferative Disorder, Melanoma (Skin), Metastatic Pancreatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm

Studies at this site

• ADAPT - A Patient Registry of the Real-world Use of Orenitram® — Running, not enrolling
• High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma — Running, not enrolling
• Phase 3 Trial of 90Y-Clivatuzumab Tetraxetan & Gemcitabine vs Placebo & Gemcitabine in Metastatic Pancreatic Cancer — Stopped early
• Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer — Completed
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. — Completed
• Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer — Completed
• A Study of CDX-011 (CR011-vcMMAE) in Patients With Advanced GPNMB-expressing Breast Cancer — Completed
• Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer — Completed
• Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain — Completed